Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2017	Mar. 31, 2016
Current assets:
Cash	$ 180,838	$ 0
Prepaid expenses and other current assets	3,221	0
Income tax receivable	105	0
Total current assets	184,164	0
Deferred tax assets	208	0
Property and equipment, net	906	0
Other assets	0	0
Total assets	185,278	0
Current liabilities:
Accounts payable	3,329	0
Accrued expenses	11,978	223
Due to Roivant Sciences Ltd. and Roivant Sciences, Inc.	3,030	0
Total current liabilities	18,337	223
Warrant liability	52	0
Deferred rent	113	0
Total liabilities	18,502	223
Commitments and contingencies (Note 10)
Shareholders’ equity (deficit):
Common shares, par value $0.000017727 per share, 564,111,242 shares authorized, 60,275,757 and 37,231,342 issued and outstanding at March 31, 2017 and March 31, 2016, respectively	1	1
Common shares subscribed	(1)	(1)
Accumulated other comprehensive income	140	0
Additional paid-in capital	251,733	1,434
Accumulated deficit	(85,097)	(1,657)
Total shareholders’ equity (deficit)	166,776	(223)
Total liabilities and shareholders’ equity (deficit)	$ 185,278	$ 0